Each 6000 mg chewable tablet contains:

 

Sarolaner (S-Sarolaner): 120.00 mg

Moxidectin: 1.44 mg

Pyrantel (as embonate): 300.00 mg

Arpraziquantel (R-Praziquantel): 150.00 mg

Excipients and flavorings: q.s.

Suralan® Quattro® is indicated for the treatment of dogs with, or at risk of, mixed parasitic infestations caused by endoparasites and ectoparasites, provided that simultaneous action is required against fleas, ticks, mites, nematodes (including gastrointestinal, pulmonary, ocular and heart) and cestodes (tapeworms), also preventing dirofilariosis and angiostrongylosis.

Administer 1 tablet orally according to the dog's weight range (40-60 kg). Recommended minimum therapeutic doses: Sarolaner: 2 mg/kg Moxidectin: 0.024 mg/kg Pyrantel (as pamoate): 5 mg/kg Arpraziquantel: 2.5 mg/kg Route of administration: Oral. Administer one tablet according to the dog's weight. It can be administered with or without food. Do not divide the tablets. Frequency: Once a month for continuous protection.

Box x 1 chewable soft tablet x 3000 mg, Box x 4 chewable soft tablets x 3000 mg,